Navigation Links
QIAGEN Expands Liquid Biopsy Pipeline with AR-V7 Test in Prostate Cancer
Date:3/31/2017

HILDEN, Germany and GERMANTOWN, Maryland, March 31, 2017 /PRNewswire/ --

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it is commercializing the Research use only AdnaTest Prostate Cancer Panel AR-V7 to detect the androgen receptor splice variant 7 (AR-V7) from liquid biopsies to investigate resistance to potential drugs for advanced prostate cancer. QIAGEN has acquired an exclusive worldwide license from Johns Hopkins University for detecting the AR-V7 biomarker in all sample and cell types through nucleic acid tests such as polymerase chain reaction (PCR) or next-generation sequencing (NGS). Johns Hopkins researchers have used AdnaTest technology in studies to evaluate the expression of AR-V7 messenger RNA in prostate cancer patients.

"Our AdnaTest workflow unlocks an important biomarker for clinical research to provide for the development of prostate cancer diagnostics in the future. Providing accurate insights from circulating tumor cells in a blood sample, our AR-V7 solution is a significant addition to our portfolio of non-invasive liquid biopsies for Personalized Healthcare," said Thierry Bernard, Senior Vice President and Head of QIAGEN's Molecular Diagnostics Business Area. "We are pleased to partner with the pioneering researchers at Johns Hopkins in developing this workflow. We plan to make the AdnaTest kit commercially available this year, as a Sample to Insight solution for clinical researchers."

Click here for the full press release

https://www.qiagen.com/about-us/press-releases/pressreleaseview?ID={55C014E9-91D1-4E5E-8FF0-822B2224081A}&lang=en

Contacts: 

QIAGEN 

Investor Relations            
John Gilardi    
+49-2103-29-11711        
e-mail: ir@QIAGEN.com             
           
Public Relations
Dr. Thomas Theuringer
+49-2103-29-11826  
e-mail: pr@QIAGEN.com


'/>"/>
SOURCE QIAGEN N.V.
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. QIAGEN Joins CANCER-ID Consortium for Liquid Biopsy Workflows
2. New Study Published in Lancet Respiratory Medicine Highlights QIAGENs QuantiFERON-TB Potential to Predict Active Tuberculosis Risk in Infants
3. QIAGENs QuantiFERON-TB Test Wins Tender for Testing of Republic of Korea Armed Forces Recruits
4. How These Research Services Stocks are Faring? -- Myriad Genetics, Qiagen, INC Research, and La Quinta
5. QIAGEN Enhances Bioinformatics Portfolio with Acquisition of OmicSoft
6. QIAGEN Announces Comprehensive Range of Enhancements for GeneReader NGS System
7. Research and Markets - Global Cervical Cancer Diagnostic Testing Market Growth of 6%, 2016-2020 with Becton, Hologic & Qiagen Dominating
8. Research Reports Coverage on Services Stocks -- Myriad Genetics, Qiagen, INC Research, and La Quinta
9. QIAGEN GeneReader NGS System to Relaunch in U.S. Market
10. QIAGENs GeneReader NGS System Streamlines Data Management for Labs
11. QIAGEN führt Flüssigbiopsie-Workflow für das GeneReader NGS-System ein
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2019)... ... June 20, 2019 , ... ERT, a ... today announced its scientific and technological experts will present a series of innovative ... (DIA) Annual Meeting in San Diego, June 23-27. , ERT’s industry-recognized thought ...
(Date:6/19/2019)... ... June 19, 2019 , ... Mahendra Kumar ... Thermal and Physical Properties of Biofield Treated Bile Salt and Proteose Peptone became ... Biophysics, Preventive Medicine, Biochemistry, Medical Technology, Pathophysiology, Molecular Biology, Science Reference and 45-Minute ...
(Date:6/19/2019)... ... June 19, 2019 , ... Senior citizens today are generally more active than ... a double-edged sword leading seniors to put off important planning until their welfare becomes ... Advisors at Elder Placement Professionals have some suggestions to help seniors make necessary plans ...
Breaking Medicine Technology:
(Date:6/19/2019)... ... June 19, 2019 , ... ... faith-based organizations, private institutions, media, and government joined Global Health Council (GHC) ... to improve universal access to water, sanitation, and hygiene (WASH) in healthcare ...
(Date:6/19/2019)... (PRWEB) , ... June 19, 2019 , ... ... today, showcasing progress made in 2018 by the Alliance and its partners. ... trends while featuring voices from across the clean cooking sector, including an entrepreneur ...
(Date:6/19/2019)... ... ... Expanding its commitment to the welfare of children through its new campaign ... Caterina’s Club during its annual West Coast gala - Notte di Savoia ... for the Southern California-based charity from funds raised by the event. The grant was ...
(Date:6/18/2019)... (PRWEB) , ... June 18, 2019 , ... ... developing non-invasive treatments for cancers and other serious diseases, announced it has received ... EMulate Therapeutics application for Humanitarian Device Exemption (HDE) for the Hælo Pediatric system. ...
(Date:6/18/2019)... (PRWEB) , ... June 18, 2019 , ... ... on addressing unmet needs in the field of urology, today announced that Aaron ... a UroLift® Center of Excellence. The designation recognizes that Dr. Aaron Berger has ...
Breaking Medicine News(10 mins):